Oral hexavalent reassortant rotavirus attenuated live vaccine
PRO-RV-1001
Phase 2 mab active
Quick answer
Oral hexavalent reassortant rotavirus attenuated live vaccine for Rotavirus Gastroenteritis is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Rotavirus Gastroenteritis
- Phase
- Phase 2
- Modality
- mab
- Status
- active